Alternatives to Imagene

AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.

AI-powered spatial biology platform for precision medicine and drug development.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Harnessing genetic data for digital insights in rare and germline disorders.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.